Dosimetric Analysis of Organs at Risk During Expiratory Gating in Stereotactic Body Radiation Therapy for Pancreatic Cancer

被引:31
|
作者
Taniguchi, Cullen M. [1 ]
Murphy, James D. [1 ]
Eclov, Neville [1 ]
Atwood, Todd F. [1 ]
Phd, Kayla N. Kielar [1 ]
Christman-Skieller, Claudia [1 ]
Mok, Ed [1 ]
Xing, Lei [1 ]
Koong, Albert C. [1 ]
Chang, Daniel T. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA
关键词
PHASE-II; RADIOTHERAPY; ADENOCARCINOMA; GEMCITABINE; SURVIVAL;
D O I
10.1016/j.ijrobp.2012.07.2366
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To determine how the respiratory phase impacts dose to normal organs during stereotactic body radiation therapy (SBRT) for pancreatic cancer. Methods and Materials: Eighteen consecutive patients with locally advanced, unresectable pancreatic adenocarcinoma treated with SBRT were included in this study. On the treatment planning 4-dimensional computed tomography (CT) scan, the planning target volume (PTV), defined as the gross tumor volume plus 3-mm margin, the duodenum, and the stomach were contoured on the end-expiration (CTexp) and end-inspiration (CTinsp) phases for each patient. A separate treatment plan was constructed for both phases with the dose prescription of 33 Gy in 5 fractions with 95% coverage of the PTV by the 100% isodose line. The dose-volume histogram (DVH) endpoints, volume of duodenum that received 20 Gy (V-20), V-25, and V-30 and maximum dose to 5 cc of contoured organ (D-5cc), D-1cc, and D-0.1cc, were evaluated. Results: Dosimetric parameters for the duodenum, including V-25, V-30, D-1cc, and D-0.1cc improved by planning on the CTexp compared to those on the CTinsp. There was a statistically significant overlap of the PTV with the duodenum but not the stomach during the CTinsp compared to the CTexp (0.38 +/- 0.17 cc vs 0.01 +/- 0.01 cc, P = .048). A larger expansion of the PTV, in accordance with a Danish phase 2 trial, showed even more overlapping volume of duodenum on the CTinsp compared to that on the CTexp (5.5 +/- 0.9 cc vs 3.0 +/- 0.8 cc, P = .0003) but no statistical difference for any stomach dosimetric DVH parameter. Conclusions: Dose to the duodenum was higher when treating on the inspiratory than on the expiratory phase. These data suggest that expiratory gating may be preferable to inspiratory breath-hold and free breathing strategies for minimizing risk of toxicity. (C) 2013 Elsevier Inc.
引用
收藏
页码:1090 / 1095
页数:6
相关论文
共 50 条
  • [1] Dosimetric Analysis of Kidney Toxicity After Stereotactic Body Radiation Therapy for Pancreatic Cancer
    Bhirud, A. R.
    Lin, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S313 - S313
  • [2] Dosimetric evaluation of simultaneous integrated boost during stereotactic body radiation therapy for pancreatic cancer
    Yang, Wensha
    Reznik, Robert
    Fraass, Benedick A.
    Nissen, Nicholas
    Hendifar, Andrew
    Wachsman, Ashley
    Sandler, Howard
    Tuli, Richard
    [J]. MEDICAL DOSIMETRY, 2015, 40 (01) : 47 - 52
  • [3] A Dosimetric Analysis of Duodenal Toxicity After Hypofractionated Stereotactic Body Radiation Therapy for Pancreatic Cancer
    Lin, C.
    Lazenby, A. J.
    Bhirud, A. R.
    Sehi, E. D.
    Zheng, D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S29 - S29
  • [4] Inter-Breath-Hold Geometric and Dosimetric Variations in Organs at Risk during Pancreatic Stereotactic Body Radiotherapy: Implications for Adaptive Radiation Therapy
    Hooshangnejad, Hamed
    Miles, Devin
    Hill, Colin
    Narang, Amol
    Ding, Kai
    Han-Oh, Sarah
    [J]. CANCERS, 2023, 15 (17)
  • [5] Stereotactic body radiation therapy (SBRT) and respiratory gating in lung cancer: dosimetric and radiobiological considerations
    Herman, Tania De La Fuente
    Vlachaki, Maria T.
    Herman, Terence S.
    Hibbitts, Kerry
    Stoner, Julie A.
    Ahmad, Salahuddin
    [J]. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2010, 11 (01): : 158 - 169
  • [6] Dosimetric Comparison of RapidArc versus CyberKnife for Stereotactic Body Radiation Therapy for Pancreatic Cancer
    Atwood, T. F.
    Mok, E.
    Lo, A.
    Xing, L.
    Koong, A. C.
    Chang, D. T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S345 - S346
  • [7] Dosimetric and Motion Analysis of Margin-Intensive Radiation Delivery by Stereotactic Body Radiation Therapy for Operable Pancreatic Cancer
    Bland, R. E.
    Heinzerling, J. H.
    Mansour, J. C.
    Schwarz, R. E.
    Ramirez, E.
    Ding, C.
    Abdulrahman, R. E.
    Timmerman, R. D.
    Meyer, J. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S339 - S339
  • [8] Stereotactic Body Radiation Therapy for Pancreatic Cancer
    Goodman, Karyn A.
    [J]. CANCER JOURNAL, 2016, 22 (04): : 290 - 295
  • [9] Dosimetric Parameters Predicting Late Toxicity in Stereotactic Body Radiation Therapy (SBRT) for Pancreatic Cancer
    Mian, O. Y.
    Moningi, S.
    Moore, J.
    Walker, A. J.
    Hacker-Prietz, A.
    McNutt, T.
    Wolfgang, C.
    Pawlik, T.
    Weiss, M.
    Herman, J. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S362 - S363
  • [10] The Role of Stereotactic Body Radiation Therapy in Pancreatic Cancer
    Stumpf, Priscilla K.
    Goodman, Karyn A.
    [J]. CURRENT CANCER THERAPY REVIEWS, 2018, 14 (01) : 46 - 54